By Oliver Griffin

PureTech Health PLC (PRTC.LN) said Tuesday that affiliate company Entrega will receive $5 million after entering a research-collaboration agreement with Eli Lilly & Co. (LLY).

Entrega will receive the sum in equity and research funding from Eli Lilly, allowing it to investigate the application of its peptide-delivery technology to Eli Lilly products and therapeutic candidates, PureTech said.

The agreement does not grant Eli Lilly a development or commercialization license for the Entrega technology, PureTech added.

Shares in PureTech Health at 0949 GMT were up 4%, or 5 pence, at 145.00 pence.

Write to Oliver Griffin at oliver.griffin@dowjones.com

(END) Dow Jones Newswires

December 19, 2017 05:15 ET (10:15 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Puretech Health Charts.
Puretech Health (LSE:PRTC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Puretech Health Charts.